Axonal and dendritic changes are associated with diabetic encephalopathy in rats: An important risk factor for Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 34, Issue 4, 2013, Pages 937-947

  Zhou, Yanping ^a,b   Luo, Yi ^b   Dai, Jiapei ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTH CENTRAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Alzheimer's disease; amyloid ; axonopathy; cognitive impairment; diabetes complications; diabetes mellitus; tau protein

Indexed keywords

AMYLOID BETA PROTEIN; GLUCOSE; STREPTOZOCIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; BRAIN REGION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITE; DIABETIC ENCEPHALOPATHY; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; GLUCOSE BRAIN LEVEL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MAZE TEST; MEMORY DISORDER; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPRAGUE DAWLEY RAT; VARICOSIS; WESTERN BLOTTING;

EID: 84876400358     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121762     Document Type: Article

References (53)

1. Biessels GJ, Kappelle AC, Bravenboer B, Erkelens DW, Gispen WH (1994) Cerebral function in diabetes mellitus. Diabetologia 37, 643-650. (Pubitemid 24210219)
2. Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH (2002) Ageing and diabetes: Implications for brain function. Eur J Pharmacol 441, 1-14. (Pubitemid 34465684)
3. Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: Longitudinal studies and their methodological limitations. Eur J Pharmacol 490, 169-175. (Pubitemid 38482170)
4. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care 28, 726-735. (Pubitemid 40315341)
5. Liang XC, Guo SS, Hagino N (2006) Current status of clinical and experimental researches on cognitive impairment in diabetes. Chin J Integr Med 12, 68-74.
6. Brands AM, Kessels RP, de Haan EH, Kappelle LJ, Biessels GJ (2004) Cerebral dysfunction in type 1 diabetes: Effects of insulin, vascular risk factors and blood-glucose levels. Eur J Pharmacol 490, 159-168. (Pubitemid 38482169)
7. Lobnig BM, Krömeke O, Optenhostert-Porst C, Wolf OT (2006) Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet Med 23, 32-39.
8. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, Jimerson DC, Hennen J, Renshaw PF, Jacobson AM (2006) Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 55, 326-333. (Pubitemid 43343260)
9. Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SA (2006) Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 49, 2474-2480. (Pubitemid 44359110)
10. Stewart R, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16, 93-112.
11. Manschot SM, Brands AM, van der Grond J, Kessels RP, Algra A, Kappelle LJ, Biessels GJ (2006) Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 55, 1106-1113. (Pubitemid 44100188)
12. Akisaki T, Sakurai T, Takata T, Umegaki H, Araki A, Mizuno S, Tanaka S, Ohashi Y, Iguchi A, Yokono K, Ito H (2006) Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab Res Rev 22, 376-384. (Pubitemid 44446433)
13. Awad N, Gagnon M, Messier C (2004) The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 26, 1044-1080. (Pubitemid 39577337)
14. Reske-Nielsen E, Lundbaek K (1968) Pathological changes in the central and peripheral nervous system of young longterm diabetics. II. The spinal cord and peripheral nerves. Diabetologia 4, 34-43.
15. DeJong RN (1977) CNS manifestations of diabetes mellitus. Postgrad Med 61, 101-107.
16. Hoffman WH, Artlett CM, ZhangW, Kreipke CW, Passmore GG, Rafols JA, SimaAA(2008) Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis. Brain Res 1238, 154-162.
17. Nelson PT, Smith CD, Abner EA, Schmitt FA, Scheff SW, Davis GJ, Keller JN, Jicha GA, Davis D, Wang-Xia W, Hartman A, Katz DG, Markesbery WR (2009) Human cerebral neuropathology of Type 2 diabetes mellitus. Biochim Biophys Acta 1792, 454-469.
18. Hirokawa N (1998) Kinesin and dynein superfamily proteins and the mechanism of organelle transport. Science 279, 519-526. (Pubitemid 28067273)
19. Barnes SJ, Opitz T, Merkens M, Kelly T, von der Brelie C, Krueppel R, Beck H (2010) Stable mossy fiber long-term potentiation requires calcium influx at the granule cell soma, protein synthesis, and microtubule-dependent axonal transport. J Neurosci 30, 12996-13004.
20. Dai J, Buijs R, SwaabD(2004) Glucocorticoid hormone (cortisol) affects axonal transport in human cortex neurons but shows resistance in Alzheimer's disease. Br J Pharmacol 143, 606-610. (Pubitemid 39524278)
21. Minoshima S, CrossD(2008) In vivo imaging of axonal transport using MRI: Aging and Alzheimer's disease. Eur J Nucl Med Mol Imaging 35(Suppl 1), S89-S92.
22. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307, 1282-1288. (Pubitemid 40299973)
23. Smith KD, Kallhoff V, Zheng H, Pautler RG (2007) In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease. Neuroimage 35, 1401-1408. (Pubitemid 46561352)
24. Xiao AW, He J, Wang Q, Luo Y, Sun Y, Zhou YP, Guan Y, Lucassen PJ, Dai JP (2011) The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease. Neurosci Bull 27, 287-299.
25. Pilcher H (2006) Alzheimer's disease could be "type 3 diabetes". Lancet Neurol 5, 388-389.
26. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ,Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7, 63-80. (Pubitemid 40387185)
27. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105, 423-438. (Pubitemid 28365027)
28. Burns JM, Donnelly JE, Anderson HS, Mayo MS, Spencer- Gardner L, Thomas G, Cronk BB, Haddad Z, Klima D, Hansen D, Brooks WM (2007) Peripheral insulin and brain structure in early Alzheimer disease. Neurology 69, 1094-1104. (Pubitemid 47517554)
29. Li ZG, ZhangW, Sima AA (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56, 1817-1824. (Pubitemid 47025451)
30. Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E (2010) Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. Exp Neurol 223, 422-431.
31. Akanmu MA,Nwabudike NL, IlesanmiOR(2009) Analgesic, learning and memory and anxiolytic effects of insulin in mice. Behav Brain Res 196, 237-241.
32. Xu WP, Shan LD, Gong S, Chen L, Zhang YJ, Yin QZ, Hisamitsu T, Jiang XH, Guo SY (2006) Forced running enhances neurogenesis in the hippocampal dentate gyrus of adult rats and improves learning ability. Acta Physiol Sinica 58, 415-420.
33. Zhang Q, Gao T, LuoY, Chen X, Gao G, Gao X, ZhouY, Dai J (2012) Transient focal cerebral ischemia/reperfusion induces early and chronic axonal changes in rats: Its importance for the risk of Alzheimer's disease. PLoS One 7, e33722.
34. Paxinos G, Watson C (2005) The Rat Brain in Stereotaxic Coordinates, Third ed. People's Medical Publishing House, Beijing.
35. Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, Perry IJ, Breteler MM, Westendorp RG (2010) A prospective analysis of elevated fasting glucose levels and cognitive function in older people: Results from PROSPER and the Rotterdam Study. Diabetes 59, 1601-1607.
36. Malone JI, Hanna S, Saporta S, Mervis RF, Park CR, Chong L, Diamond DM (2008) Hyperglycemia not hypoglycemia alters neuronal dendrites and impairs spatial memory. Pediatr Diabetes 9, 531-539.
37. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Metaanalysis of randomised controlled trials. BMJ 343, d4169.
38. Serbedzija P, Madl JE, Ishii DN (2009) Insulin and IGF-I prevent brain atrophy and DNA loss in diabetes. Brain Res 1303, 179-194.
39. Sima AA, Zhang W, Kreipke CW, Rafols JA, Hoffman WH (2009) Inflammation in diabetic encephalopathy is prevented by C-peptide. Rev Diabet Stud 6, 37-42.
40. Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM (2004) Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16R-28R.
41. Ahtiluoto S, Polvikoski T, Peltonen M, Solomon A, Tuomilehto J, Winblad B, Sulkava R, Kivipelto M (2010) Diabetes, Alzheimer disease, and vascular dementia: A populationbased neuropathologic study. Neurology 75, 1195-2202.
42. Mandelkow E, Mandelkow EM (1995) Microtubules and microtubule-associated proteins. Curr Opin Cell Biol 7, 72-81.
43. Fernyhough P, Gallagher A, Averill SA, Priestley JV, Hounsom L, Patel J, Tomlinson DR (1999) Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy. Diabetes 48, 881-889. (Pubitemid 29153090)
44. Lamprecht R, LeDoux J (2004) Structural plasticity and memory. Nat Rev Neurosci 5, 45-54. (Pubitemid 38076183)
45. Avila J, Díaz-Nido J (2004) Tangling with hypothermia. Nat Med 10, 460-461. (Pubitemid 38667901)
46. MagariñosAM, McEwen BS (2000) Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc Natl Acad Sci U S A 97, 11056-11061.
47. Joghataie MT, Roghani M, Jalali MR, Baluchnejadmojarad T, SharayeliM(2007) Dendritic spine changes in medial prefrontal cortex of male diabetic rats using Golgi-impregnation method. Arch Iran Med 10, 54-58. (Pubitemid 46188966)
48. Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, Abner EL, Markesbery WR (2007) Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: Neuritic plaques and neurofibrillary tangles "do count" when staging disease severity. J Neuropathol Exp Neurol 66, 1136-1146. (Pubitemid 350294663)
49. Haroutunian V, Schnaider-Beeri M, Schmeidler J, Wysocki M, Purohit DP, Perl DP, Libow LS, Lesser GT, Maroukian M, Grossman HT (2008) Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch Neurol 65, 1211-1217.
50. Robinson JL, Geser F, Corrada MM, Berlau DJ, Arnold SE, Lee VM, Kawas CH, Trojanowski JQ (2011) Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old. Brain 134, 3708-3715.
51. ValenteT, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N (2010) Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus. Neurobiol Dis 37, 67-76.
52. Holmes C, Boche D,Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebocontrolled phase I trial. Lancet 372, 216-223. (Pubitemid 351978111)
53. Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L (2012) Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 69, 198-207.